Ilyang develops new influenza antiviral drug

Ilyang Pharm said it has filed a patent application for new antiviral agent, which could be used to both prevent and reduce the duration of fever and other symptoms associated with the influenza.

The mechanism of the shikimic acid-free antiviral medication is different from that of neuraminidase (NA) inhibitors, such as oseltamivir (Tamiflu) and zanamavir (Relenza), according to the company....